YOLFTbeta
VN

CHINA HEALTH GRP HD-10

VNL1 · F · Healthcare / Diagnostics & Research

0.0005EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.0005
Open0.0005
Day Range0.0005 – 0.0005
52-Week Range0.0005 – 0.01
Volume0
Market Cap1.11M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta-0.31
50-Day Avg0.0007
200-Day Avg0.0035

About

China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Xia Guo MBA, MSc, Ph.D.
  • Employees33
  • HeadquartersBuilding 17, Beijing, China, Germany
  • Websitehttps://www.chgi.net

Leadership

  • Mr. Xia Guo MBA, MSc, Ph.D.Executive Chairman · b. 1965
  • Mr. Guo RaymondExecutive Director & Chief Artificial Intelligence Officer · b. 2001
  • Mr. Liang LiFinancial Director
  • Dr. Tuo JinJoint Chief Technology Officer and Member of Scientific Advisory Board · b. 1953
  • Dr. Xuemei SongHead of HR Mgmt Dept · b. 1968
  • Mr. Tsz Ngo YuCompany Secretary · b. 1986
  • Dr. Yiu Kwong Sun B.S., M.B., M.D.Adviser for Medical Affairs and Member of Corporate Advisory Board · b. 1943

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue83.60M13.09M21.43M26.45M28.56M
Growth (%)--84.34%+63.67%+23.47%+7.98%
Cost of Revenue19.74M7.35M13.21M16.39M12.17M
Gross Profit63.86M5.74M8.21M10.07M16.39M
Gross Margin76.38%43.87%38.33%38.05%57.39%
Operating Expense21.77M21.80M66.54M24.91M31.54M
Operating Income42.09M-16.06M-58.33M-14.85M-15.15M
Operating Margin50.34%-122.67%-272.26%-56.12%-53.04%
EBITDA--15.66M-58.10M-14.24M-14.42M
EBITDA Margin--119.62%-271.16%-53.83%-50.49%
Net Income36.33M-15.83M-58.01M-14.52M-14.96M
Net Income Margin43.45%-120.90%-270.78%-54.88%-52.38%
Interest Expense15.00K17.00K0--
Interest Expense % of Total Revenue0.02%0.13%0.00%--

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets194.32M178.63M119.35M100.96M87.08M
Total Liabilities38.75M36.74M35.17M31.24M32.32M
Total Equity155.57M142.32M84.82M70.35M55.39M
Cash11.36M4.06M4.14M14.19M21.82M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.28M-5.16M1.12M10.28M7.59M
Capital Expenditure006.00M1.76M10.00K
Free Cash Flow-10.28M-5.16M-4.88M8.52M7.58M
FCF to OCF100.00%100.00%-435.59%82.88%99.87%

Key Statistics & Ratios

Market Cap1.11M
Enterprise Value4.23M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.04
Price / Book0.06
EPS0.00
Book Value0.0086
Revenue (TTM)29.90M
Gross Profit (TTM)17.26M
EBITDA-13.41M
Profit Margin-47.38%
Operating Margin48.68%
Return on Equity-19.86%
Return on Assets-8.49%
Shares Outstanding995.35M
Shares Float288.87M
Beta-0.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%